Updated: June 13, 2026
About the program
Program type
Investment stage
Investment focus areas
cell therapy
CBD
biomarkers
protein
celle therapy
proteomics
life sciences
metabolomics
pharmaceuticals
biotech
transcriptomics
drug
therapeutic
life sciences tools
pharma
medicine
IVD
genomics
therapeutics
psychedelic
CGT
psychedelics
in vitro diagnostics
mRNA
cannabis
metabolites
bio
drugs
biopharma
medicines
gene therapy
molecules
Location
Investment offer
Can lead rounds
No
Lead preference
Never
Funding requirements
We invest in early-stage life sciences ventures, including medicine, biotech, and bioengineering.